CSE bulletin 2026-0228

The Canadian Securities Exchange has determined that Nirvana Life Sciences Inc. has not met the continued listing requirements as set out in CSE Policy 2, Appendix A, Section 2.9.

Pursuant to Policy 6, Section 2.4, the issuer may not rely on confidential price protection, nor may the issuer complete any financing without prior exchange approval.

In accordance with Policy 3, Section 5.1, the .X extension is added to the listed securities of issuers that the exchange has deemed to be inactive.

Issuer:  Nirvana Life Sciences

Old symbol:  NIRV

New symbol:  NIRV.X

Effective date:  Feb. 27, 2026